University of California San Francisco
Helen Diller Family Comprehensive Cancer Center

UCSF at Dreamforce 2017: Precision Cancer Care and Public Health Tech

By Nina Bai | UCSF.edu | November 3, 2017

UCSF at Dreamforce 2017: Precision Cancer Care and Public Health Tech

One of UC San Francisco’s groundbreaking cancer programs will be prominently featured at the 2017 Dreamforce conference through an interactive exposition and a talk by two researchers.

UCSF at Dreamforce

“Tech and Health: Connection as Cure” (live stream)
Monday, Nov. 6
9:30 a.m.-10 a.m.
Featuring Eleni Linos

“Bringing ‘Wisdom’ To Breast Cancer Research” (live stream)
Monday, Nov. 6
10:30 a.m.-10:45 a.m.
Featuring Laura Esserman

“Healthcare and Life Sciences: Compliance in the Cloud”
Monday, Nov. 6
1 p.m.-1:40p.m.
Featuring Jamie Lam, Victor Vargas Reyes

“How UCSF is Driving Personalized and Connected Hereditary Cancer Care”
Tuesday, Nov. 7
10 a.m.-10:20 a.m.
Featuring Alan Ashworth, Pamela Munster

The University’s participation in the annual conference also includes a speaker on how collaboration between technology companies and health researchers can accelerate benefits for patients and the public.

Dreamforce is an annual conference put on by cloud computing company Salesforce to showcase some of the nation’s thought leaders, industry pioneers and innovators. This year’s conference, with the theme "Blaze Your Trail," is estimated to draw more than 170,000 attendees to San Francisco. UCSF participates each year to highlight the latest innovations in health care and research.

UCSF will be one of six major brands featured at the Dreamforce Expo, which will be open throughout the four-day conference that begins Nov. 6. UCSF’s interactive exhibit will showcase the work of the Center for BRCA Research at the UCSF Helen Diller Family Comprehensive Cancer Center (HDFCCC), one of only two centers for hereditary cancers in the United States. The BRCA1 and BRCA2 genes are known to increase the risk of breast, ovarian, pancreatic, prostate and some other cancers.

The interactive exhibit will guide visitors through a storyline of an HDFCC patient who may be at higher risk of cancer. Visitors can choose to follow the story from three points of view – patient, care team, or researcher – in learning about hereditary cancer care, from genetic testing for the BRCA genes to counseling and personalized preventive care plans.

 

Read more at UCSF.edu